Lindstrom J, Uusitupa M, Tuomilehto J, Peltonen M. Following in the Footsteps of the North Karelia Project: Prevention of Type 2 Diabetes. Glob Heart. 2016;11(2):223-8.
Lindstrom J, Uusitupa M, Tuomilehto J, Peltonen M
2016
June
Glob Heart
1.39
Prof. Jaakko Tuomilehto
Leng J, Liu G, Zhang C, Xin S, Chen F, Li B, Tian H, Yu Z, Tuomilehto J, Hu G, Yang X. Physical activity, sedentary behaviors and risk of gestational diabetes mellitus: a population-based cross-sectional study in Tianjin, China. Eur J Endocrinol. 2016;174(6):763-73.
Leng J, Liu G, Zhang C, Xin S, Chen F, Li B, Tian H, Yu Z, Tuomilehto J, Hu G, Yang X.
2016
June
Eur J Endocrinol
3.892
Prof. Jaakko Tuomilehto
Laatikainen T, Nissinen A, Kastarinen M, Jula A, Tuomilehto J. Blood Pressure, Sodium Intake, and Hypertension Control: Lessons From the North Karelia Project. Glob Heart. 2016;11(2):191-9.
Laatikainen T, Nissinen A, Kastarinen M, Jula A, Tuomilehto J.
2016
June
Glob Heart
1.39
Prof. Jaakko Tuomilehto
Jolle A, Midthjell K, Holmen J, Tuomilehto J, Carlsen SM, Shaw J, Asvold BO. Impact of sex and age on the performance of FINDRISC: the HUNT Study in Norway. BMJ Open Diabetes Res Care, 2016;4(1):e000217.
Jolle A, Midthjell K, Holmen J, Tuomilehto J, Carlsen SM, Shaw J, Asvold BO.
2016
June
BMJ Open Diabetes Res Care
N/A
Prof. Jaakko Tuomilehto
Shaltout AA, Channanath AM, Thanaraj TA, Omar D, Abdulrasoul M, Zanaty N, et al. Ketoacidosis at first presentation of type 1 diabetes mellitus among children: a study from Kuwait. Sci Rep. 2016;6:27519.
Shaltout AA, Channanath AM, Thanaraj TA, Omar D, Abdulrasoul M, Zanaty N, et al
2016
June
Sci Rep
5.228
Family Medicine & Pediatric Unit; and Population Genomics and Genetic Epidemiology unit
AlSaggaf W, Asiri M, Ajlan B, Afif AB, Khalil R, Salman AB, Alghamdi A, Bashawieh O, Alamoudi A, Aljahdali A, Tuomilehto J, et al. Reported Benefits of Insulin Therapy for Better Glycemic Control in Type 2 Diabetic Patients-Is This Applicable in Saudi Patients? Clin Med Insights Endocrinol Diabetes.2016;9:13-7.
AlSaggaf W, Asiri M, Ajlan B, Afif AB, Khalil R, Salman AB, Alghamdi A, Bashawieh O, Alamoudi A, Aljahdali A, Tuomilehto J, et al.
2016
June
Clin Med Insights Endocrinol Diabetes
1.35
Prof. Jaakko Tuomilehto
Baothman OA, Zamzami MA, Taher I, Abubaker J, Abu-Farha M. The role of Gut Microbiota in the development of obesity and Diabetes. Lipids Health Dis. 2016;15:108.
Baothman OA, Zamzami MA, Taher I, Abubaker J, Abu-Farha M.
2016
June
Lipids Health Dis
2.137
BMBU
Laatikainen L, Ojamo M, Rudanko SL, Summanen P, Keinanen-Kiukaanniemi S, Tuomilehto J, Herrala S, Uusitalo H. Improving visual prognosis of the diabetic patients during the past 30 years based on the data of the Finnish Register of Visual Impairment. Acta Ophthalmol. 2016;94(3):226-31.
Laatikainen L, Ojamo M, Rudanko SL, Summanen P, Keinanen-Kiukaanniemi S, Tuomilehto J, Herrala S, Uusitalo H.
2016
May
Acta Ophthalmol
3.032
Prof. Jaakko Tuomilehto
Takkunen MJ, Schwab US, de Mello VD, Eriksson JG, Lindström J, Tuomilehto J, Uusitupa MI; DPS Study Group. Longitudinal associations of serum fatty acid composition with type 2 diabetes risk and markers of insulin secretion and sensitivity in the Finnish Diabetes Prevention Study. Eur J Nutr. 2016;55(3):967-79.
Takkunen MJ, Schwab US, de Mello VD, Eriksson JG, Lindström J, Tuomilehto J, Uusitupa MI; DPS Study Group.
2016
April
Eur J Nutr.
3.1
Prof. Jaakko Tuomilehto
NCD Risk Factor Collaboration (NCD-RisC), Tuomilehto J. et al. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet. 2016;387(10026):1377-96.
NCD Risk Factor Collaboration (NCD-RisC), Tuomilehto J. et al.
2016
April
Lancet
44.002
Prof. Jaakko Tuomilehto
Bahijri SM, Jambi HA, Al Raddadi RM, Ferns G, Tuomilehto J. The Prevalence of Diabetes and Prediabetes in the Adult Population of Jeddah, Saudi Arabia--A Community-Based Survey. PLoS One. 2016;11(4):e0152559.
Bahijri SM, Jambi HA, Al Raddadi RM, Ferns G, Tuomilehto J.
2016
April
PLoS One
3.234
Prof. Jaakko Tuomilehto
Alroughani R, Ashkanani A, Al-Hashel J, Khan R, Thussu A, Alexander KJ, et al. Consensus recommendations for the diagnosis and treatment of multiple sclerosis in Kuwait. Clin Neurol Neurosurg. 2016;143:51-64.
Alroughani R, Ashkanani A, Al-Hashel J, Khan R, Thussu A, Alexander KJ, et al.
2016
April
Clin Neurol Neurosurg
1.12
Clinical Trials
Davies MJ, Gray LJ, Troughton J, Gray A, Tuomilehto J, Farooqi A, Khunti K, Yates T, Let's Prevent Diabetes Team. A community based primary prevention programme for type 2 diabetes integrating identification and lifestyle intervention for prevention: the Let's Prevent Diabetes cluster randomised controlled trial. Prev Med. 2016;84:48-56.
Davies MJ, Gray LJ, Troughton J, Gray A, Tuomilehto J, Farooqi A, Khunti K, Yates T, Let's Prevent Diabetes Team.
2016
March
Prev Med
3.086
Prof. Jaakko Tuomilehto
Hartman ML, Goodson JM, Shi P, Vargas J, Yaskell T, Stephens D, Cugini M, Hasturk H, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K, Welty F. Unhealthy Phenotype as Indicated by Salivary Biomarkers: Glucose, Insulin, VEGF-A, and IL-12p70 in Obese Kuwaiti Adolescents. J Obes. 2016;2016:6860240.
Hartman ML, Goodson JM, Shi P, Vargas J, Yaskell T, Stephens D, Cugini M, Hasturk H, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K, Welty F
2016
March
J Obes
4.15
Epidemiology and Public Health; Nutrition Department and Functional Genomics
Hartman ML, Goodson JM, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K. Salivary Biomarkers in Pediatric Metabolic Disease Research. Pediatr Endocrinol Rev. 2016;13(3):602-11.
Hartman ML, Goodson JM, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K.
2016
March
Pediatr Endocrinol Rev.
2.15
Epidemiology and Public Health; Nutrition Department and Functional Genomics
Arefanian H, Tredget EB, Mok DC, Ramji Q, Rafati S, Rodriguez-Barbosa J, et al. Porcine Islet-Specific Tolerance Induced by the Combination of Anti-LFA-1 and Anti-CD154 mAbs Is Dependent on PD-1. Cell Transplant. 2016;25(2):327-42.
Arefanian H, Tredget EB, Mok DC, Ramji Q, Rafati S, Rodriguez-Barbosa J, et al.
2016
February
Cell Transplant
3.427
Islet Biology
Vaatainen S, Cederberg H, Roine R, Keinänen-Kiukaanniemi S, Saramies J, Uusitalo H, Tuomilehto J, Martikainen J. Does Future Diabetes Risk Impair Current Quality of Life? A Cross-Sectional Study of Health-Related Quality of Life in Relation to the Finnish Diabetes Risk Score (FINDRISC). PLoS One. 2016;11(2):e0147898.
Vaatainen S, Cederberg H, Roine R, Keinänen-Kiukaanniemi S, Saramies J, Uusitalo H, Tuomilehto J, Martikainen J
2016
February
PLoS One
3.234
Prof. Jaakko Tuomilehto
Liu H, Zhang S, Wang L, Leng J, Li W, Li N, Li M, Qiao Y, Tian H, Tuomilehto J, et al. Fasting and 2-hour plasma glucose, and HbA1c in pregnancy and the postpartum risk of diabetes among Chinese women with gestational diabetes. Diabetes Res Clin Pract.. 2016;112:30-6.
Liu H, Zhang S, Wang L, Leng J, Li W, Li N, Li M, Qiao Y, Tian H, Tuomilehto J, et al.
2016
February
Diabetes Res Clin Pract
3.045
Prof. Jaakko Tuomilehto